Vyome Biosciences Private
Latest round
- Series D
Last raised
- Dec 2018
Total raised
- $36M
Investors
- 7
About Vyome Biosciences Private
Founded in 2010 and based in New Delhi, India, Vyome Biosciences Private Limited is a biopharmaceutical company that develops drugs for dermatology care; offering products to treat dandruff, diabetic foot ulcers, pigmentation disorders, acne and skin pathogens.
Who invested in Vyome Biosciences Private
7 investors across 5 rounds
See all investors in Vyome Biosciences Private
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vyome Biosciences Private
Who invested in Vyome Biosciences Private?
Vyome Biosciences Private has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vyome Biosciences Private raised?
Vyome Biosciences Private has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Vyome Biosciences Private last raise money?
Vyome Biosciences Private's most recent round on record is a Series D, in Dec 2018.
What does Vyome Biosciences Private do?
Founded in 2010 and based in New Delhi, India, Vyome Biosciences Private Limited is a biopharmaceutical company that develops drugs for dermatology care; offering products to treat dandruff, diabetic foot ulcers, pigmentation disorders, acne and skin pathogens.
Where is Vyome Biosciences Private headquartered?
Vyome Biosciences Private is headquartered in New Delhi, India.
Which VCs invest in companies like Vyome Biosciences Private?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Vyome Biosciences Private's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Vyome Biosciences Private? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.